These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 24865974)

  • 1. Biomarkers of CD4+ T-cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndrome.
    Chakrabarti LA; Boucherie C; Bugault F; Cumont MC; Roussillon C; Breton G; Patey O; Chêne G; Richert L; Lortholary O;
    AIDS; 2014 Jul; 28(11):1593-602. PubMed ID: 24865974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
    Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efavirenz, tenofovir and emtricitabine combined with first-line tuberculosis treatment in tuberculosis-HIV-coinfected Tanzanian patients: a pharmacokinetic and safety study.
    Semvua HH; Mtabho CM; Fillekes Q; van den Boogaard J; Kisonga RM; Mleoh L; Ndaro A; Kisanga ER; van der Ven A; Aarnoutse RE; Kibiki GS; Boeree MJ; Burger DM
    Antivir Ther; 2013; 18(1):105-13. PubMed ID: 23043067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome.
    Tan HY; Yong YK; Andrade BB; Shankar EM; Ponnampalavanar S; Omar SF; Narendran G; Kamarulzaman A; Swaminathan S; Sereti I; Crowe SM; French MA
    AIDS; 2015 Feb; 29(4):421-31. PubMed ID: 25565499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for increased immune reconstitution in response to Mycobacterium tuberculosis antigens in tuberculosis HIV-infected, antiretroviral-naïve patients.
    da Silva TP; Giacoia-Gripp CBW; Schmaltz CA; Sant'Anna FM; Saad MH; Matos JA; de Lima E Silva JCA; Rolla VC; Morgado MG
    BMC Infect Dis; 2017 Sep; 17(1):606. PubMed ID: 28874142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of monocytes in the development of Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome.
    Tran HT; Van den Bergh R; Vu TN; Laukens K; Worodria W; Loembé MM; Colebunders R; Kestens L; De Baetselier P; Raes G;
    Immunobiology; 2014 Jan; 219(1):37-44. PubMed ID: 23958034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of T-Lymphocyte Activation Related to Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in Persons With Advanced HIV.
    Tibúrcio R; Barreto-Duarte B; Naredren G; Queiroz ATL; Anbalagan S; Nayak K; Ravichandran N; Subramani R; Antonelli LRV; Satagopan K; Anbalagan K; Porter BO; Sher A; Swaminathan S; Sereti I; Andrade BB
    Front Immunol; 2021; 12():757843. PubMed ID: 34691079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial.
    Laureillard D; Marcy O; Madec Y; Chea S; Chan S; Borand L; Fernandez M; Prak N; Kim C; Dim B; Nerrienet E; Sok T; Delfraissy JF; Goldfeld AE; Blanc FX;
    AIDS; 2013 Oct; 27(16):2577-86. PubMed ID: 24096631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.
    Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Nfanyana K; Bellamy SL; MacGregor RR; Gross R; Weissman D; Bisson GP
    Lancet Infect Dis; 2015 Apr; 15(4):429-38. PubMed ID: 25672566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome.
    Meintjes G; Wilkinson KA; Rangaka MX; Skolimowska K; van Veen K; Abrahams M; Seldon R; Pepper DJ; Rebe K; Mouton P; van Cutsem G; Nicol MP; Maartens G; Wilkinson RJ
    Am J Respir Crit Care Med; 2008 Nov; 178(10):1083-9. PubMed ID: 18755923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial.
    Lortholary O; Roussillon C; Boucherie C; Padoin C; Chaix ML; Breton G; Rami A; Veziris N; Patey O; Caumes E; May T; Molina JM; Robert J; Tod M; Fagard C; Chêne G;
    J Antimicrob Chemother; 2016 Mar; 71(3):783-93. PubMed ID: 26679250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TB-IRIS, T-cell activation, and remodeling of the T-cell compartment in highly immunosuppressed HIV-infected patients with TB.
    Haridas V; Pean P; Jasenosky LD; Madec Y; Laureillard D; Sok T; Sath S; Borand L; Marcy O; Chan S; Tsitsikov E; Delfraissy JF; Blanc FX; Goldfeld AE;
    AIDS; 2015 Jan; 29(3):263-73. PubMed ID: 25486415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection.
    Worodria W; Menten J; Massinga-Loembe M; Mazakpwe D; Bagenda D; Koole O; Mayanja-Kizza H; Kestens L; Mugerwa R; Reiss P; Colebunders R;
    Antivir Ther; 2012; 17(5):841-8. PubMed ID: 22543224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the complement system in monocytes contributes to tuberculosis-associated immune reconstitution inflammatory syndrome.
    Tran HT; Van den Bergh R; Loembé MM; Worodria W; Mayanja-Kizza H; Colebunders R; Mascart F; Stordeur P; Kestens L; De Baetselier P; Raes G;
    AIDS; 2013 Jul; 27(11):1725-34. PubMed ID: 23807270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Activation of γδ T Cells and the γδ2
    Pean P; Nouhin J; Ratana M; Madec Y; Borand L; Marcy O; Laureillard D; Fernandez M; Barré-Sinoussi F; Weiss L; Scott-Algara D
    Front Immunol; 2019; 10():2018. PubMed ID: 31507608
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term treatment with raltegravir or efavirenz combined with tenofovir/emtricitabine for treatment-naive human immunodeficiency virus-1-infected patients: 156-week results from STARTMRK.
    Rockstroh JK; Lennox JL; Dejesus E; Saag MS; Lazzarin A; Wan H; Walker ML; Xu X; Zhao J; Teppler H; Dinubile MJ; Rodgers AJ; Nguyen BY; Leavitt R; Sklar P;
    Clin Infect Dis; 2011 Oct; 53(8):807-16. PubMed ID: 21921224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune reconstitution inflammatory syndrome with tuberculosis: a common problem in Ethiopian HIV-infected patients beginning antiretroviral therapy.
    Ali K; Klotz SA
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(3):198-202. PubMed ID: 21521804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenofovir/emtricitabine/efavirenz plus rosuvastatin decrease serum levels of inflammatory markers more than antiretroviral drugs alone in antiretroviral therapy-naive HIV-infected patients.
    Calza L; Vanino E; Salvadori C; Manfredi R; Colangeli V; Cascavilla A; Di Bari MA; Motta R; Viale P
    HIV Clin Trials; 2014; 15(1):1-13. PubMed ID: 24518210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome.
    Tadokera R; Meintjes G; Skolimowska KH; Wilkinson KA; Matthews K; Seldon R; Chegou NN; Maartens G; Rangaka MX; Rebe K; Walzl G; Wilkinson RJ
    Eur Respir J; 2011 May; 37(5):1248-59. PubMed ID: 20817712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy.
    Elliott JH; Vohith K; Saramony S; Savuth C; Dara C; Sarim C; Huffam S; Oelrichs R; Sophea P; Saphonn V; Kaldor J; Cooper DA; Chhi Vun M; French MA
    J Infect Dis; 2009 Dec; 200(11):1736-45. PubMed ID: 19874177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.